ClinicalTrials.gov
ClinicalTrials.gov Menu

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01134484
Recruitment Status : Unknown
Verified July 2012 by Michele Cavo, Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi.
Recruitment status was:  Active, not recruiting
First Posted : June 2, 2010
Last Update Posted : July 20, 2012
Sponsor:
Collaborator:
Janssen-Cilag S.p.A.
Information provided by (Responsible Party):
Michele Cavo, Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Actual Primary Completion Date : August 2008
  Estimated Study Completion Date : December 2015
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):